Saturday 17 October 2026
Export SI’s income statement to Excel — free account
Shoulder Innovations, Inc.
Shoulder Innovations, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $47.3 million, up 49.6% from fiscal 2024. In the quarter to June 2026, revenue grew 56.0%, EPS grew 99.7%, free cash flow fell 52.4% and total debt was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.
18.09
0.28
−1.52%
Follow SI
Shoulder Innovations, Inc. (SI) P/E ratio
Shoulder Innovations, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 0.0× (October 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 4 more quarters | Free account |
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| NPCE NeuroPace, Inc. compare | n/m |
| SENS Senseonics Holdings, Inc. compare | n/m |
| OFIX ORTHOFIX MEDICAL INC. compare | n/m |
| CERS Cerus Corporation compare | n/m |
| RCEL Avita Medical Inc. compare | n/m |
| SI Shoulder Innovations, Inc. | n/m |
| CV CapsoVision, Inc. compare | 2.1× |
| BWAY Brainsway Ltd. Sponsored ADR compare | 24.8× |
| VMD Viemed Healthcare, Inc. compare | 24.9× |
| Medical Devices industry median | 23.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)